Last update: Dec. 21, 2013

Rimonabant

High Risk for breastfeeding


Poorly safe. Evaluate carefully.
Use safer alternative or interrupt breastfeeding 3 to 7 T½.
Read the Comment.

In spite of the fact that it is highly attached to serum proteins should be avoid while nursing because it is a newly appeared medication, a long standing effect (10 – 15 days), possibility to alter the baby’s appetite, needs to be taken for a long time (months or years), poor effect on weight loosing.

Hypo-caloric diet and exercise are advisable.

Breastfeeding women recover their pre-pregnancy body weight sooner than bottle-feeding mothers.

Alternatives

Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Group

Rimonabant belongs to this group or family:

Tradenames

Main tradenames from several countries containing Rimonabant in its composition:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. Baja - Low %
Molecular weight 464 daltons
Protein Binding 100 %
Tmax 2 hours
T1/2 4000 hours

References

We are working to add the scientific references of this product. It will be available soon. If you wish to have access to this information, please let us know by leaving your comment in the opinion section below.

Total visits

1,722

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write to us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana from Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM